NCT02446080

Brief Summary

Constipation is defined as a disorder characterized by persistent difficulty to evacuate or a feeling of incomplete evacuation and / or infrequent bowel movements. Many factors contribute to the onset of constipation, such as changes in dietary intake and fluid intake, decrease in consumption of products containing fiber, intake of drugs or laxatives, decreased intestinal motility and physical inactivity. The objective was to evaluate the effect of consumption of dairy products with probiotics on constipation. Randomized double-blind clinical trial in the city of Bom Retiro do Sul / RS, Brazil. They were recruited 60 female patients aged 20-50 years after application of the Rome III criteria (World Gastroenterology Organization, 2010) and Range Bristol (World Gastroenterology Organisation, 2010) were diagnosed with constipation. Patients were randomized into two groups, where one group will receive the milk drink with probiotics and the other group will receive a probiotic milk drink without (control group). The milk beverage consumption period shall be 60 days where each patient will consume 150 ml of milk drink a day, with breakfast or morning snack.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2014

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 13, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 15, 2015

Completed
Last Updated

May 15, 2015

Status Verified

May 1, 2015

Enrollment Period

2 months

First QC Date

May 13, 2015

Last Update Submit

May 14, 2015

Conditions

Keywords

ConstipationProbioticsWomen

Outcome Measures

Primary Outcomes (1)

  • Improvement of symptoms of constipation

    Improvement of symptoms of constipation by ROME III criteria and Bristol scale.

    60 days

Secondary Outcomes (1)

  • Increased number of bowel movements

    60 days

Study Arms (2)

Probiotic Group

EXPERIMENTAL

Milk drink with probiotic culture (150 mL/daily) for 60 days.

Dietary Supplement: Milk drink with probiotic culture

Control Group

ACTIVE COMPARATOR

Milk drink (150 mL/daily) for 60 days.

Dietary Supplement: Milk drink

Interventions

The Probiotc group was asked to drink 150 ml per day of dairy drinks with probiotic culture

Probiotic Group
Milk drinkDIETARY_SUPPLEMENT

The control group was asked to drink 150 ml per day of dairy drinks.

Control Group

Eligibility Criteria

Age20 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Having a diagnosis of constipation;
  • Have aged between 20 and 50 years;
  • Being female.

You may not qualify if:

  • Patients with diabetes;
  • Patients pregnant and lactating women;
  • Patients with diarrhea, with previous gastrointestinal disorders;
  • Current or recent consumption of antibiotics, anti-inflammatory drugs, laxatives or other drugs;
  • Patients with diseases that alter bowel habits, such as food allergies and intolerances, ulcerative colitis, chron's disease and irritable bowel syndrome.
  • Patients who have lactose intolerance or dislike of milk drink.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Constipation

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nutrition Course Professor

Study Record Dates

First Submitted

May 13, 2015

First Posted

May 15, 2015

Study Start

December 1, 2014

Primary Completion

February 1, 2015

Study Completion

March 1, 2015

Last Updated

May 15, 2015

Record last verified: 2015-05